Thermogenesis Holdings Inc. Share Price Today: Live Updates & Key Insights

Thermogenesis Holdings Inc. share price today is $0.3164, up -24.36%. The stock opened at $0.34001 against the previous close of $0.4183, with an intraday high of $0.355 and low of $0.3101.

Thermogenesis Holdings Inc. Share Price Chart

Thermogenesis Holdings Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Thermogenesis Holdings Inc. Share Price Performance

$0.3164 -0.2436(-24.36%) THMO at 23 Mar 2026 03:29 PM Medical Devices
Lowest Today 0.3101
Highest Today 0.355
Today’s Open 0.34001
Prev. Close 0.4183
52 Week High 1.82
52 Week Low 0.32
Day’s Range: Low 0.3101 High 0.355
52-Week Range: Low 0.32 High 1.82
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

Thermogenesis Holdings Inc. Institutional Holdings

Raymond James & Associates 0.82

Vanguard Group Inc 0.45

Vanguard Institutional Extnd Mkt Idx Tr 0.45

Virtu Financial LLC 0.33

Geode Capital Management, LLC 0.13

Morgan Stanley - Brokerage Accounts 0.12

Fidelity Extended Market Index 0.11

Tower Research Capital LLC 0.09

UBS Group AG 0.09

Fidelity Series Total Market Index 0.02

BlackRock Inc 0.02

Fidelity Nasdaq Composite Index 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Advisor Group Holdings, Inc. 0.00

Royal Bank of Canada 0.00

Wells Fargo & Co 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

Qube Research & Technologies 0.00

Atlantic Trust Group, LLC 0.00

Bank of America Corp 0.00

FMR Inc 0.00

Hanson Mcclain Inc 0.00

Parallel Advisors, LLC 0.00

Sound Income Strategies 0.00

SSgA U.S. Extended Market Index Class I 0.00

State St US Extended Mkt Indx NL Cl C 0.00

TWO SIGMA SECURITIES, LLC 0.00

Thermogenesis Holdings Inc. Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Thermogenesis Holdings Inc. Fundamentals

Market Cap 3.18 M

PB Ratio 0.5597

PE Ratio 0.0

Enterprise Value 7.51 M

Total Assets 11.23 M

Volume 200452

Thermogenesis Holdings Inc. Company Financials

Annual Revenue FY23:9715000 9.7M, FY22:10483000 10.5M, FY21:9294000 9.3M, FY20:9744000 9.7M, FY19:13047000 13.0M

Annual Profit FY23:2363000 2.4M, FY22:2710000 2.7M, FY21:3493000 3.5M, FY20:1259000 1.3M, FY19:5696000 5.7M

Annual Net worth FY23:-14394000 -14.4M, FY22:-11270000 -11.3M, FY21:-18284000 -18.3M, FY20:-23509000 -23.5M, FY19:-13928000 -13.9M

Quarterly Revenue Q1/2024:2406000 2.4M, Q4/2023:2406000 2.4M, Q3/2023:2194000 2.2M, Q2/2023:2273000 2.3M, Q1/2023:2572000 2.6M

Quarterly Profit Q1/2024:-38000 -0.0M, Q4/2023:-38000 -0.0M, Q3/2023:395000 0.4M, Q2/2023:469000 0.5M, Q1/2023:1105000 1.1M

Quarterly Net worth Q1/2024:-7014000 -7.0M, Q4/2023:-7014000 -7.0M, Q3/2023:-3615000 -3.6M, Q2/2023:-2260000 -2.3M, Q1/2023:-5086000 -5.1M

About Thermogenesis Holdings Inc. & investment objective

Company Information ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

Organisation Medical Devices

Employees 25

Industry Medical Devices

CEO Dr. Xiaochun Xu M.B.A., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Thermogenesis Holdings Inc. FAQs

What is the share price of Thermogenesis Holdings Inc. today?

The current share price of Thermogenesis Holdings Inc. is $0.3164.

Can I buy Thermogenesis Holdings Inc. shares in India?

Yes, Indian investors can buy Thermogenesis Holdings Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Thermogenesis Holdings Inc. shares in India?

You can easily invest in Thermogenesis Holdings Inc. shares from India by:

Can I buy fractional shares of Thermogenesis Holdings Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Thermogenesis Holdings Inc.?

Thermogenesis Holdings Inc. has a market cap of $3.18 M.

In which sector does Thermogenesis Holdings Inc. belong?

Thermogenesis Holdings Inc. operates in the Medical Devices sector.

What documents are required to invest in Thermogenesis Holdings Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Thermogenesis Holdings Inc.?

The PE ratio of Thermogenesis Holdings Inc. is N/A and the PB ratio is 0.56.